Anders Kvanta
Clinical Neuroscience,
Section for Ophtalmology and Vision,
Department of Clinical Neuroscience,
Section of Eye and Vision,
St Erik Eye Hospital,
Clinical Neuroscience, Section for Ophtalmology and Vision,
Department of Clinical Neuroscience, Section of Eye and Vision, St Erik Eye Hospital
Karolinska Institutet
Anders Kvanta has not added Biography.
If you are Anders Kvanta and would like to personalize this page please email our Author Liaison for assistance.
Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.
Ophthalmology Jun, 2012 | Pubmed ID: 22424833
Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina.
Investigative ophthalmology & visual science Jun, 2004 | Pubmed ID: 15161865
Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice.
Experimental eye research Feb, 2005 | Pubmed ID: 15670794
Choroidal biopsies for intraocular tumors of indeterminate origin.
American journal of ophthalmology Dec, 2005 | Pubmed ID: 16376642
Photodynamic therapy of experimental choroidal neovascularization in the mouse.
Current eye research Sep, 2006 | Pubmed ID: 16966149
Angiomotin regulates endothelial cell migration during embryonic angiogenesis.
Genes & development Aug, 2007 | Pubmed ID: 17699752
Involvement of purinergic P2 receptors in experimental retinal neovascularization.
Current eye research Mar, 2008 | Pubmed ID: 18350440
Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ).
Acta ophthalmologica Dec, 2010 | Pubmed ID: 19900206
Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial.
European journal of ophthalmology Nov-Dec, 2011 | Pubmed ID: 21484753
Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.
Ophthalmology Dec, 2012 | Pubmed ID: 22902212
Stem cell-based treatment in geographic atrophy: promises and pitfalls.
Acta ophthalmologica Feb, 2014 | Pubmed ID: 23890249
Seasonality and incidence of central retinal vein occlusion in Sweden: a 6-year study.
Ophthalmic epidemiology Apr, 2015 | Pubmed ID: 25777308
Xeno-Free and Defined Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Functionally Integrate in a Large-Eyed Preclinical Model.
Stem cell reports Jan, 2016 | Pubmed ID: 26724907
Vitamin D Deficiency in Patients with Central Retinal Vein Occlusion: A Case Control Study.
Current eye research Mar, 2017 | Pubmed ID: 27348601
Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal Neovascularization.
Scientific reports Feb, 2017 | Pubmed ID: 28186209
Integration of Subretinal Suspension Transplants of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in a Large-Eyed Model of Geographic Atrophy.
Investigative ophthalmology & visual science 02, 2017 | Pubmed ID: 28241319
A novel in vivo model of puncture-induced iris neovascularization.
PloS one , 2017 | Pubmed ID: 28658313
Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration.
Nutrients Sep, 2017 | Pubmed ID: 28961167
A model to study complement involvement in experimental retinal degeneration.
Upsala journal of medical sciences Feb, 2018 | Pubmed ID: 29436895
